Ciglitazone is an antidiabetic drug of the thiazolidinedione structural class. Ciglitazone is a potent and selective PPARγ ligand. It binds to the PPARγ ligand-binding domain with an EC50 of 3.0 µM.1 Ciglitazone is active in vivo as an anti-hyperglycemic agent in the ob/ob mouse model.1
1
Willson, T.M., Cobb, J.E., Cowan, D.J., et al. The structure-activity relationship between peroxisome proliferator-activated receptor γ agonism and the antihyperglycemic activity of thiazolidinediones. J Med Chem39665-668(1996).
Room temperature
in continental US; may vary elsewhere
SMILES
Copy SMILES to clipboard
O=C1NC(=O)C(S1)Cc1ccc(cc1)OCC1(C)CCCCC1
Background Reading
Willson, T.M., Cobb, J.E., Cowan, D.J., et al. The structure-activity relationship between peroxisome proliferator-activated receptor γ agonism and the antihyperglycemic activity of thiazolidinediones. J Med Chem39665-668(1996).
Ciglitazone is available in the following screening
library: